Neuroendocrine Tumor G1 — Trials

Neuroendocrine Tumor G1 — Trials · CancerIndex

Clinical trials

Registered studies

65 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 51–65 of 65 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00031681	7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007)	completed	Phase 1	41	National Cancer Institute (NCI)NIH	1	Sep 30, 2013	clinicaltrials
NCT00602082	Capecitabine and Streptozocin With or Without Cisplatin in Treating Patients With Unresectable or Metastatic Neuroendocrine Tumors	completed	Phase 2	84	Cambridge University Hospitals NHS Foundation TrustOTHER	1	Aug 7, 2013	clinicaltrials
NCT00003427	Oxaliplatin Plus Irinotecan in Treating Patients With Metastatic Gastrointestinal Cancer	completed	Phase 1	36	Memorial Sloan Kettering Cancer CenterOTHER	1	Jun 26, 2013	clinicaltrials

Data updated 22 days agoSource updated Sep 30, 2013source: clinicaltrials